Weight Loss Medications Are Becoming More and More Popular, What Are The Risks.

Several weight loss injectables have gained popularity in recent years, offering individuals new options for managing their weight. These medications work through various mechanisms, targeting different aspects of appetite regulation, metabolism, and fat storage. With a range of choices available, it’s essential to understand how each injectable functions and what makes them unique. Here are some notable examples of these weight loss injectables that are currently on the market:

1. Wegovy (semaglutide): Approved by the FDA for weight management, Wegovy is an injectable medication that mimics a hormone involved in appetite regulation. It helps reduce excess weight and maintain weight reduction over the long term [1].
2. Saxenda (liraglutide): Another injectable medication approved for weight loss, Saxenda works by mimicking a hormone that targets areas of the brain regulating appetite. It is often prescribed for individuals with obesity or those who are overweight with accompanying health issues such as type 2 diabetes or high blood pressure [1].
3. Ozempic (semaglutide): While primarily used for managing type 2 diabetes, Ozempic has also been shown to aid in weight loss. It is similar to Wegovy but prescribed at a different dose [1].
4. Zepbound (tirzepatide): Recently approved for weight loss, Zepbound is anticipated to become widely used due to its effectiveness. It was initially approved under the name Mounjaro for diabetes management before receiving approval for weight loss [1][4].

These injectables offer different approaches to managing weight and are typically used alongside lifestyle changes such as diet and exercise for optimal results.

Sources:

• [1] FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight
• [4] The New Weight-Loss Drugs and Cancer